0001771706-26-000004.txt : 20260622 0001771706-26-000004.hdr.sgml : 20260622 20260622122552 ACCESSION NUMBER: 0001771706-26-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260622 DATE AS OF CHANGE: 20260622 EFFECTIVENESS DATE: 20260622 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vireo Growth Inc. CENTRAL INDEX KEY: 0001771706 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-588062 FILM NUMBER: 261105797 BUSINESS ADDRESS: STREET 1: 207 SOUTH 9TH STREET CITY: MINNEAPOLIS STATE: MN ZIP: 55402 BUSINESS PHONE: 604-617-5421 MAIL ADDRESS: STREET 1: 207 SOUTH 9TH STREET CITY: MINNEAPOLIS STATE: MN ZIP: 55402 FORMER COMPANY: FORMER CONFORMED NAME: Goodness Growth Holdings, Inc. DATE OF NAME CHANGE: 20210607 FORMER COMPANY: FORMER CONFORMED NAME: Vireo Health International, Inc. DATE OF NAME CHANGE: 20190326 D 1 primary_doc.xml X0708 D LIVE 0001771706 Vireo Growth Inc. 207 SOUTH 9TH STREET MINNEAPOLIS MN MINNESOTA 55402 604-617-5421 BRITISH COLUMBIA, CANADA Darien Business Development Corp. Goodness Growth Holdings, Inc. Vireo Health International, Inc. Corporation true John Mazarakis 207 South 9th Street Minneapolis MN MINNESOTA 55402 Executive Officer Director Kyle Kingsley 207 South 9th Street Minneapolis MN MINNESOTA 55402 Director Judd Nordquist 207 South 9th Street Minneapolis MN MINNESOTA 55402 Director Ross Hussey 207 South 9th Street Minneapolis MN MINNESOTA 55402 Director Victor E. Mancebo 207 South 9th Street Minneapolis MN MINNESOTA 55402 Director Tyson Macdonald 207 South 9th Street Minneapolis MN MINNESOTA 55402 Executive Officer Michael Steiner 207 South 9th Street Minneapolis MN MINNESOTA 55402 Director Chris Hagedorn 207 South 9th Street Minneapolis MN MINNESOTA 55402 Director Other Decline to Disclose 06b false 2026-06-05 true true true true true Each Convertible Note will convert on or after the second anniversary of closing, on a pre-share consolidation basis, into subordinate voting shares at a deemed price of US$0.62 per share. true 0 13662648 13662648 0 false 7 0 0 0 false Vireo Growth Inc. /s/ Tyson Macdonald Tyson Macdonald Chief Financial Officer 2026-06-19